rxstatShortages › Loxapine

Loxapine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Loxapine products are in shortage in Canada (4 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
4 / 10
In shortage since
Mar 10, 2017
Reports on file
18
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-LOXAPINE
5MG · TABLET · APOTEX INC
DIN 02237651 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-LOXAPINE
10MG · TABLET · APOTEX INC
DIN 02237652 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-LOXAPINE
25MG · TABLET · APOTEX INC
DIN 02237653 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-LOXAPINE
50MG · TABLET · APOTEX INC
DIN 02237654 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
XYLAC
50MG · TABLET · PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
DIN 02230840 · ended Sep 21, 2018 · Disruption of the manufacture of the drug.
Resolved
XYLAC
5MG · TABLET · PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
DIN 02230837 · ended Sep 18, 2018 · Disruption of the manufacture of the drug.
Resolved
LOXAPAC IM
50MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02169991 · ended Aug 8, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLAC
25MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02230839 · ended May 31, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLAC
10MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02230838 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLAC
2.5MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02242868 · ended Sep 20, 2024 · Shortage of an inactive ingredient or component.
Resolved
LOXAPAC IM
50MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02169991 · ended Sep 16, 2024 · Demand increase for the drug.
Resolved
XYLAC
2.5MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02242868 · ended May 9, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 18 reports. All reports are on file with Health Canada.

What's happening

Loxapine is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Loxapine is classified under “ANTIPSYCHOTICS” (ATC N05AH).

Recent changes

Common questions

When will Loxapine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Loxapine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antipsychotics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.